NO864760D0 - Nye fluorholdige 1,4-dihydropyridiner, fremgangsmaate til deres fremstilling, samt deres anvendelse som legemiddel. - Google Patents

Nye fluorholdige 1,4-dihydropyridiner, fremgangsmaate til deres fremstilling, samt deres anvendelse som legemiddel.

Info

Publication number
NO864760D0
NO864760D0 NO864760A NO864760A NO864760D0 NO 864760 D0 NO864760 D0 NO 864760D0 NO 864760 A NO864760 A NO 864760A NO 864760 A NO864760 A NO 864760A NO 864760 D0 NO864760 D0 NO 864760D0
Authority
NO
Norway
Prior art keywords
dihydropyridines
medicine
procedures
preparation
fluorous
Prior art date
Application number
NO864760A
Other languages
English (en)
Norwegian (no)
Inventor
Egbert Wehinger
Horst Meyer
Andreas Knorr
Stanislav Kazda
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO864760D0 publication Critical patent/NO864760D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO864760A 1985-12-13 1986-11-26 Nye fluorholdige 1,4-dihydropyridiner, fremgangsmaate til deres fremstilling, samt deres anvendelse som legemiddel. NO864760D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853544211 DE3544211A1 (de) 1985-12-13 1985-12-13 Neue, fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
NO864760D0 true NO864760D0 (no) 1986-11-26

Family

ID=6288416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864760A NO864760D0 (no) 1985-12-13 1986-11-26 Nye fluorholdige 1,4-dihydropyridiner, fremgangsmaate til deres fremstilling, samt deres anvendelse som legemiddel.

Country Status (17)

Country Link
US (1) US4798840A (fr)
EP (1) EP0225574B1 (fr)
JP (1) JPS62145064A (fr)
KR (1) KR870005993A (fr)
CN (1) CN86108499A (fr)
AT (1) ATE52773T1 (fr)
AU (1) AU588656B2 (fr)
DE (2) DE3544211A1 (fr)
DK (1) DK599486A (fr)
ES (1) ES2014975B3 (fr)
FI (1) FI865057A (fr)
GR (1) GR3000488T3 (fr)
HU (1) HU197304B (fr)
IL (1) IL80931A0 (fr)
NO (1) NO864760D0 (fr)
PT (1) PT83897B (fr)
ZA (1) ZA869376B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0657432B1 (fr) * 1993-12-10 2003-03-12 Bayer Ag 1,4-Dihydropyridines substitués par un groupement phényle avec une activité cérébrale
CZ20031779A3 (cs) * 2000-12-29 2004-10-13 Bioorganicsáb@V Způsob přípravy amlodipinuŹ jeho derivátů a jejich prekurzorů
KR101294702B1 (ko) * 2006-10-18 2013-08-08 (주)유케이케미팜 S-(-)-암로디핀입체이성질체의 제조방법
DE102009049137A1 (de) 2009-10-12 2011-04-14 Rhenotherm Kunststoffbeschichtungs Gmbh Beschichtungsaufbau

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5395976A (en) * 1977-02-02 1978-08-22 Sankyo Co Ltd Cyclopropyl-substituted-dihydropyridine derivatives
US4177278A (en) * 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4258042A (en) * 1980-04-11 1981-03-24 Usv Pharmaceutical Corporation Antihypertensive pyridines and compositions
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
EP0125803A3 (fr) * 1983-04-27 1987-01-21 FISONS plc Dihydropyridines pharmaceutiquement actives

Also Published As

Publication number Publication date
HUT45013A (en) 1988-05-30
JPS62145064A (ja) 1987-06-29
DE3544211A1 (de) 1987-06-19
DK599486D0 (da) 1986-12-12
FI865057A0 (fi) 1986-12-11
ZA869376B (en) 1987-09-30
GR3000488T3 (en) 1991-06-28
DK599486A (da) 1987-06-14
IL80931A0 (en) 1987-03-31
ES2014975B3 (es) 1990-08-01
DE3671221D1 (de) 1990-06-21
AU6639686A (en) 1987-06-18
PT83897A (en) 1987-01-01
KR870005993A (ko) 1987-07-08
EP0225574A1 (fr) 1987-06-16
US4798840A (en) 1989-01-17
ATE52773T1 (de) 1990-06-15
AU588656B2 (en) 1989-09-21
CN86108499A (zh) 1987-07-15
HU197304B (en) 1989-03-28
PT83897B (en) 1988-12-14
FI865057A (fi) 1987-06-14
EP0225574B1 (fr) 1990-05-16

Similar Documents

Publication Publication Date Title
ATE9793T1 (de) 5-oxo- und 5-thioxoproline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DK114783D0 (da) Hidtil ukendte forbindelser, fremgangsmader til deres fremstilling samt deres anvendelse som laegemidler
DK188288D0 (da) 1-phenyl-3-naphthalenyloxypropanaminer, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske midler indeholdende disse
DK38982A (da) Fremgangsmaade til fremstilling af 2-penemforbindelser
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
NO158578C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater.
DK0506434T3 (da) Thiazolidinon- og oxazolidinon-derivater, fremstilling deraf og deres anvendelse som vasodilaterende midler
NO864760D0 (no) Nye fluorholdige 1,4-dihydropyridiner, fremgangsmaate til deres fremstilling, samt deres anvendelse som legemiddel.
DE68909855D1 (de) 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydroisochinolin-Derivate, ihre Herstellung und ihre therapeutische Verwendung.
DK435285A (da) Furo(3,2-c)pyridinderivater, fremgangsmaade til fremstilling deraf samt laegemiddel indeholdende saadanne derivater
DK432086A (da) Fremgangsmaade til fremstilling af beta-lactamforbindelser eller saltederaf
DK176085D0 (da) 4-(nitrophenyl)-tetrahydropyridiner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
DK109285A (da) Laegemidler paa basis af piperidinderivater, piperidinderivater ogfremgangsmaade til deres fremstilling
DK469381A (da) Piperidinderivater og fremgangsmaade til deres fremstilling
NO932779L (no) Tetrahydronaftalenderivater, fremgangsmaate for deres fremstilling og anvendelse derav
SE8303131D0 (sv) Isoquinoline derivatives
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister